Related Experiment Videos
Pain following herpes zoster: implications for management
1Pain Management Clinic, Level 4, Bristol Royal Infirmary, Bristol BS2 8HW, UK. rwjbristol@doctors.org.uk
Summary
Preventing post-herpetic neuralgia in herpes zoster patients is crucial. Early antiviral treatment for high-risk individuals reduces complications and healthcare costs, though better therapies are needed for established pain.
Area of Science:
- Neurology
- Infectious Diseases
- Pain Management
Background:
- Herpes zoster (shingles) can lead to debilitating post-herpetic neuralgia (PHN).
- Effective prevention and management of PHN are critical to reduce patient suffering and healthcare burden.
- Current treatment strategies for established PHN offer partial relief, highlighting the need for improved therapies.
Purpose of the Study:
- To review the management strategies for herpes zoster-associated pain.
- To emphasize the importance of preventing post-herpetic neuralgia.
- To discuss current and needed therapeutic interventions for PHN.
Main Methods:
- Review of management principles for herpes zoster and associated pain.
- Discussion of risk factors and early intervention strategies for PHN prevention.
- Overview of established treatments for post-herpetic neuralgia.
Main Results:
- Prompt antiviral treatment in high-risk individuals can prevent progression to post-herpetic neuralgia.
- Early intervention reduces disability, distress, and healthcare resource utilization.
- Tricyclic antidepressants and certain anticonvulsants/opioids show efficacy in established PHN, but are not universally effective.
Conclusions:
- Preventing post-herpetic neuralgia through early recognition and antiviral therapy is a key management goal.
- While current treatments for established PHN have some efficacy, further research is needed to develop more effective options.
- Optimizing the management of herpes zoster-associated pain requires a dual approach of prevention and improved treatment strategies.